The phrase "activity burden" is correct and usable in written English.
It can be used to describe the weight or load of tasks or responsibilities associated with a particular activity.
Example: "The team is feeling the activity burden as they try to meet the tight deadlines for the project."
Alternatives: "task load" or "workload pressure".
The comparative effects of liposomal and free DTPA at similar doses were examined in terms of limitation of alpha activity burden in rats receiving various treatment regimens.
Quantitative analysis of amino acids concentrations in culture supernatants revealed an arginase activity specifically burden by G-MDSCs and an IDO activity burden by both M- and G-MDSCs.
This suggests that the measurements of FFT power and epileptiform activity burden are more sensitive in finding drug effects than event duration and interevent interval alone.
The epileptiform activity burden (the proportion of time a slice is having epileptiform activity) is another measurement parameter that combines the event duration and the interevent interval.
Similar to the FFT power, the epileptiform activity burden decreased significantly (paired t‐test, P < 0.001; Figs. 5G, 6D; Table 2).
It remains unknown why older slices with a low [Cl−]i have persistent spontaneous epileptiform activity with a high epileptiform activity burden.
The effects of suppressing emotions and motor activities burden the function of an organism resulting in several neuromuscular disorders [ 32].
We hypothesized that as our combined PET/MRI parameters using the ratio between metabolo-volumetric parameter and ADC reflects metabolic activity, tumor burden and cellularity, they could show better prognostic value than each PET or MRI parameter.
We calculated an estimate of how trial-based research activity reflects burden of disease as a 'research: need' ratio, by dividing the number of people randomised with each category of mental health problem by the WHO's Years Lost due to Disability (YLD) for the same category.
To assess these treatment goals, annualized relapse rates (ARRs) or time to first relapse and disability progression, as measured by the expanded disability status scale (EDSS), are the primary clinical endpoints of phase 3 studies of therapies for RRMS, with magnetic resonance imaging (MRI) measures of disease activity and burden (CNS lesions) as secondary endpoints.
Yet, looking closer at the themes addressed it becomes obvious that patients also complained about reduced ability to execute their daily activities, symptom burden while being active and the social and emotional consequences of reduced physical activity.
